Importantly, the highly supportive microenvironment of the CBH model (combined with the less vigorous cytotoxic T cell response) allows some EBV mutants (including EBNA3C and LMP1 mutants) that are non-transforming in vitro to form lymphomas in vivo [43–45]. Here, PDLIM7 is linked to lymphoma.